Deep Brain Stimulation

Deep Brain Stimulation is a neurosurgical procedure that uses a neurostimulator to stimulate specific regions of the brain for treatment of movement disorders. Here is the latest research.

January 19, 2021

Modulation of Neuronal Excitability by Low-intensity Ultrasound in Two Principal Neurons of Rat Anteroventral Cochlear Nucleus

IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control
Zhengrong LinLong Meng
January 16, 2021

Ambulatory surface electromyography with accelerometry for evaluating daily motor fluctuations in Parkinson's disease

Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology
Saara M RissanenEero Pekkonen
January 16, 2021
Open Access

Kynurenic Acid Electrochemical Immunosensor: Blood-Based Diagnosis of Alzheimer's Disease

Jose Marrugo-RamírezJosep Samitier
January 18, 2021

Alterations of Neuronal Dynamics as a Mechanism for Cognitive Impairment in Epilepsy

Current Topics in Behavioral Neurosciences
Pierre-Pascal Lenck-Santini, Sophie Sakkaki
January 18, 2021

Effects of repeated anodal transcranial direct current stimulation on auditory fear extinction in C57BL/6J mice

Brain Stimulation
Andries Van SchuerbeekDimitri De Bundel
January 19, 2021

Safety and Feasibility of Nucleus Accumbens Surgery for Drug Addiction: A Systematic Review

Neuromodulation : Journal of the International Neuromodulation Society
Paula Alejandra NavarroWilliam Omar Contreras López
January 17, 2021
Open Access

The sensitivity of ECG contamination to surgical implantation site in adaptive closed-loop neurostimulation systems

BioRxiv : the Preprint Server for Biology
W.-J. NeumannTimothy Denison
January 19, 2021
Open Access

Intracranial electrical stimulation alters meso-scale network integration as a function of network topology

BioRxiv : the Preprint Server for Biology
William Hedley ThompsonJ. M. Shine
January 15, 2021

Ethical examination of deep brain stimulation's 'last resort' status

Journal of Medical Ethics
Ian Stevens, Frederic Gilbert
January 20, 2021

State-dependent responses to intracranial brain stimulation in a patient with depression

Nature Medicine
Katherine W ScangosAndrew D Krystal
January 16, 2021
Open Access

Whole brain dynamics during optogenetic self-stimulation of the medial prefrontal cortex in mice

Communications Biology
Christopher G CoverHanbing Lu
January 20, 2021

Effects of subthalamic deep brain stimulation on fixational eye movements in Parkinson's disease

Journal of Computational Neuroscience
Sinem Balta BeylergilFatema F Ghasia
January 16, 2021

Exome sequencing in paediatric patients with movement disorders

Orphanet Journal of Rare Diseases
Anna Ka-Yee KwongCheuk-Wing Fung
January 14, 2021
Open Access

A patient with a 6q22.1 deletion and a phenotype of non-progressive early-onset generalized epilepsy with tremor

Epilepsy & Behavior Reports
Kazuhiro HaginoyaShigeo Kure
January 19, 2021
Case Report

Variable frequency stimulation of sacral neuromodulation in black-zone overactive bladder patients: a case report

Translational Andrology and Urology
Lingfeng MengYaoguang Zhang
January 17, 2021

Impulsivity Markers in Parkinsonian Subthalamic Single-Unit Activity

Movement Disorders : Official Journal of the Movement Disorder Society
Federico MicheliAlberto Mazzoni
January 20, 2021

Comparison of efficacy of deep brain stimulation and focused ultrasound in parkinsonian tremor: a systematic review and network meta-analysis

Journal of Neurology, Neurosurgery, and Psychiatry
Fabin LinGuoen Cai
January 20, 2021

Deep brain stimulation for Parkinson's disease

Fortschritte der Neurologie-Psychiatrie
Petyo NikolovAlfons Schnitzler
January 17, 2021

Long-term effects of pallidal and thalamic deep brain stimulation in Myoclonus Dystonia

European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies
Patricia KrauseAndrea A Kühn

Sign up to follow this feed and discover related papers.

Related Feeds


TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.


This feed focuses mechanisms underlying addiction and addictive behaviour including heroin and opium dependence, alcohol intoxication, gambling, and tobacco addiction.

Alpha-Synuclein Structure & Function

α-Synuclein is an integral component of Lewy bodies which are comprised of protein clumps and are a pathological hallmark of Parkinson’s disease. Here is the latest research on α-synuclein structure and function.

Amygdala and Midbrain Dopamine

The midbrain dopamine system is widely studied for its involvement in emotional and motivational behavior. Some of these neurons receive information from the amygdala and project throughout the cortex. When the circuit and transmission of dopamine is disrupted symptoms may present. Here is the latest research on the amygdala and midbrain dopamine.

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

Antisense Oligonucleotide Therapies: ND

Antisense oligonucleotides are synthetic DNA oligomers that hybridize to a target RNA. This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases.

Astrocytes & Huntington’s Disease

Astrocytes are abundant within the central nervous system and their dysfunction has been thought to be an important contributor to some neurodegenerative diseases, in particular Huntington’s disease. Damage to these cells may make neurons more susceptible to degeneration. Here is the latest research on astrocytes and Huntington’s disease.

© 2021 Meta ULC. All rights reserved